Acadia Healthcare downgraded on rising legal and insurance costs, shares drop
Acadia Healthcare (NASDAQ:ACHC) shares plunged more than 10% after the company was downgraded to an ‘Underperform' rating by Bank of America analysts, who warned that rising insurance and legal costs will pressure profitability into 2026. The analyst also lowered their price objective on Acadia Healthcare to $13.
Acadia Healthcare Cuts 2025 Outlook After Liability Bomb Went Off
ACHC cuts its 2025 outlook as liability costs soar, with surging claims and weaker reinsurance sharply hitting earnings and EBITDA.
Acadia Healthcare Company, Inc. (ACHC) Presents at UBS Global Healthcare Conference 2025 Transcript
Acadia Healthcare Company, Inc. ( ACHC ) UBS Global Healthcare Conference 2025 November 11, 2025 2:45 PM EST Company Participants Christopher Hunter - CEO & Director Todd Young - Chief Financial Officer Conference Call Participants Joseph Overman - UBS Investment Bank, Research Division Presentation Joseph Overman UBS Investment Bank, Research Division Hey, everyone. I'm Joseph Overman, I'm on the health care managed care and facilities team here at UBS.
Acadia Healthcare Company, Inc. (ACHC) Q3 2025 Earnings Call Transcript
Acadia Healthcare Company, Inc. ( ACHC ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Brian Farley - Executive VP, General Counsel & Secretary Christopher Hunter - CEO & Director Todd Young - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Pito Chickering - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Ryan Langston - TD Cowen, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today.
New Strong Sell Stocks for Nov. 6
ACHC, FWRD and CENX have been added to the Zacks Rank #5 (Strong Sell) List on Nov. 6, 2025.
Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.91 per share a year ago.
Analysts Estimate Acadia Healthcare (ACHC) to Report a Decline in Earnings: What to Look Out for
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia & ECU Health Expand Behavioral Care Access in North Carolina
ACHC opens a 144-bed hospital with ECU Health in Greenville, NC, boosting care access and expanding its behavioral health reach.
Acadia Healthcare Q2 Earnings Beat on Growing Admission Volumes
ACHC beats Q2 earnings estimates despite lower average length of stay and higher expenses, thanks to increased patient days.
Acadia Healthcare: Earnings Selloff Surprising, But Now Is Not The Time To Buy
Acadia Healthcare Company, Inc.'s Q2 results showed revenue growth and profitability, but ongoing DOJ/SEC investigations and Medicaid headwinds continue to weigh on sentiment. Despite ACHC undervaluation based on P/S and P/E ratios, I remain cautious due to persistent reputational issues and softness in Medicaid-driven business. Management is focused on growth and expansion, but legal costs, CFO resignation, and policy uncertainty present ongoing risks.
Acadia Healthcare Company, Inc. (ACHC) Q2 2025 Earnings Call Transcript
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q2 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants Christopher Howal Hunter - CEO & Director Heather Dixon - Chief Financial Officer Patrick Thomas Feeley - Senior Vice President of Investor Relations Conference Call Participants Albert J. William Rice - UBS Investment Bank, Research Division Matthew Dale Gillmor - KeyBanc Capital Markets Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Philip Chickering - Deutsche Bank AG, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Raj Kumar - Stephens Inc., Research Division Benjamin Whitman Mayo - Leerink Partners LLC, Research Division Ryan M.
Acadia Healthcare (ACHC) Beats Q2 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.91 per share a year ago.
